From April 1, 2022 to June 30, 2022, the company has repurchased 1,396,705 shares, representing 3.95% for KRW 23,170 million. With this, the company has completed the repurchase of 1,608,038 shares, representing 4.54% for KRW 27,152.64 million under the buyback announced on March 24, 2022.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
6,620 KRW | +1.38% |
|
-0.30% | -26.20% |
2023 | Access Bio, Inc. acquired an unknown minority stake in CuraPatient Inc. | CI |
2023 | Tranche Update on Access Bio, Inc.'s Equity Buyback Plan announced on March 24, 2022. | CI |
1st Jan change | Capi. | |
---|---|---|
-26.20% | 162M | |
-6.66% | 12.02B | |
-19.37% | 6.81B | |
+4.89% | 5.74B | |
+27.24% | 5.47B | |
-21.19% | 3.59B | |
+6.64% | 2.56B | |
+30.09% | 2.25B | |
-66.53% | 2.24B | |
-13.05% | 2.21B |
- Stock Market
- Equities
- A950130 Stock
- News Access Bio, Inc.
- Tranche Update on Access Bio, Inc.'s Equity Buyback Plan announced on March 24, 2022.